Status:
UNKNOWN
Investigation of Early Hormonotherapy Efficacy of Prostate Cancer
Lead Sponsor:
Kaunas University of Medicine
Conditions:
Prostate Cancer
Eligibility:
MALE
40-80 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether early hormonotherapy is effective in the treatment of high risk prostate cancer patients after radical prostatectomy.
Detailed Description
The primary purpose of this study is to evaluate the hypothesis, that early administration of adjuvant hormonotherapy (triptorelin) can prolong survival data for high risk patients. Control group (ran...
Eligibility Criteria
Inclusion
- preoperative PSA\>20ng/ml
- postoperative PSA \>0.2 ng/ml
- Gleason \> 7
- pT3b
- signated infomed consent
Exclusion
- neoadjuvant hormonaltherapy before RP
- R1 RP
- N+ RP
- unstable cncomitant conditions
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
End Date :
January 1 2020
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT00375687
Start Date
August 1 2005
End Date
January 1 2020
Last Update
September 13 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology dep. of Kaunas University of Medicine
Kaunas, Lithuania, 50009